Please login to the form below
Mark Mallon
This page shows the latest Mark Mallon news and features for those working in and with pharma, biotech and healthcare.
China approves Ironwood Pharma’s IBS treatment
The good news coincides with big changes at the US specialist pharma company, with a new CEO, AstraZeneca's Mark Mallon, and a splitting out into two separate companies. ... Mark Mallon, CEO, Ironwood Pharmaceuticals and Cyclerion. Ironwood and Allergan
Latest news
-
AZ’s Sean Bohen to exit after business overhaul; report
Chief commercial officer Mark Mallon has taken on the CEO role at US biotech Ironwood Pharmaceuticals, while Medimmune research head Bahija Jallal agreed to take the helm of UK biotech company
-
AstraZeneca unveils reorg, hires controversial José Baselga as cancer chief
The reshuffle coincides with the departure of two senior leaders: chief commercial officer Mark Mallon, who leaves to become chief executive of US biotech Ironwood Pharmaceuticals, and Bahija Jallal, who leaves
-
Grünenthal buys Zomig rights as AZ slimming drive continues
Mark Mallon, EVP, global product and portfolio strategy at AstraZeneca, said: “Grünenthal is an established partner with expertise in the treatment of pain.
-
AZ agrees to $320m deal for Zoladex
Mark Mallon, executive vice president of global product and portfolio strategy at AZ, said: “This agreement allows us to retain a significant share of the value of Zoladex in the US
-
AstraZeneca sets sights on China with Takeda deal
The company's executive vice president, international - Mark Mallon - said the increased investment "reinforces our commitment to bring innovative medicines from our exciting pipeline of targeted and biological medicines to patients
AZ’s Sean Bohen to exit after business overhaul; report
AstraZeneca unveils reorg, hires controversial José Baselga as cancer chief
Grünenthal buys Zomig rights as AZ slimming drive continues
AstraZeneca sets sights on China with Takeda deal
More from news
Approximately 0 fully matching, plus 8 partially matching documents found.
Latest Intelligence
-
China: AstraZeneca’s new engine for growth and innovation
AstraZeneca’s Mark Mallon talks to PME about how its long-term investment in China is paying off. ... Mark Mallon is one of the chief architects of AstraZeneca’s current success in China.
-
Biopharma's Future: Made in China
Mark Mallon is executive vice president of Global Product &Portfolio Strategy at AstraZeneca, and before that spent many years as the company’s head of China and then the wider Asia ... AZ's Mark Mallon. “We have built the right culture there,”
China: AstraZeneca’s new engine for growth and innovation
Biopharma's Future: Made in China
More from intelligence
Approximately 1 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Senior Consultant, Pricing & Market Access Consultancy, circ...
-
circa £100K package
- Principal/ Senior/ Medical Writer – Global Med Ed and Comms Agen...
-
Highly competitive salary
- Account Manager - Healthcare Consultancy
-
Salary depending on experience
-
Events Executive
-
Depending on Experience
- Project Director, Healthcare Marketing Agency patient focus Lond...
-
Highly competitive salary
- Digital Project Director, Healthcare Marketing Agency patient fo...
-
Highly competitive salary
-
Digital account director
-
Competitive
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
- Mixing AZ and Pfizer COVID-19 vaccines increases antibody levels
- CHMP rejects Kyowa Kirin’s Parkinson’s disease drug
- Novavax announces further delays for regulatory filings of COVID-19 vaccine
- Google’s DeepMind opens ‘breakthrough’ protein database to the world
- Merck & Co’s sales bounce back in ‘ongoing recovery from COVID-19’
- Lilly and Kumquat Biosciences link up in $2bn-plus immuno-oncology deal
- Michael J. Fox Foundation and IBM reveal new AI model for Parkinson’s disease
- BMS’ Q2 results beat expectations with strong performance across core therapy areas
- Amanda Pritchard becomes NHS England’s first female chief executive
- Understanding the ‘real world’ starts and ends with the patient
No results were found
PMHub
Fishawack Health
Fishawack Health is the leading global commercialization partner for the modern life science era. Established in 2001 and headquartered in...
Latest intelligence
- Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
- The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
- Employee wellbeing in creative agencies: three tips to get you started
- Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
- Managing unhelpful pressure in your creative agency: the human approach
- Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...
